Renal Reading List

Page Information

Content provided by NU Department of Medicine

Updated 07/05

Renal Reading List

You may need to log in to the Health SmartLibrary before you can view any of the full-text articles in the following list.

For articles from MD Consult, we can only provide a link to the journal in MD Consult (not directly to the article). Users will need to search for the article within the MD Consult database. Please see relevant articles in the reading lists for further instructions.

Material from UpToDate can only be accessed in NMH, NU Chicago, or NU Evanston buildings. Remote access is not permitted.

Concerning Copyright Restrictions

The Copyright law of the United States (Title 17, United States Code) governs the making of photocopies or other reproductions of copyright material. Under certain conditions specified in the law, libraries and archives are authorized to furnish a photocopy or other reproduction, which is not to be "used for any purposes other than private study, scholarship or research." If a user makes a request for, or later uses, a photocopy or reproduction for purposes in excess of "fair use", that user may be liable for copyright infringement.

Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996 May 30;334(22):1448-60.

Ifudu O. Care of patients undergoing hemodialysis. N Engl J Med. 1998 Oct 8;339(15):1054-62.

Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000 Jul-Aug;20(4):396-411.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000 Jan 20;342(3):145-53.

Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001 Sep 20;345(12):861-9.

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001 Sep 20;345(12):851-60.

Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999 Jul 31;354(9176):359-64.

Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994 Mar 31;330(13):877-84.

Wing LMH, Reid CM, Philip Ryan P, Beilin LJ, Brown MA, M.D., Jennings GLR, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ, for the Second Australian National Blood. Pressure Study Group.A Comparison of Outcomes with Angiotensin-Converting-Enzyme Inhibitors and Diuretics for Hypertension in the Elderly. N Eng J Med. 2003 Feb 13; 348(7):583-92.

Bianchi S, Bigazzi R, Carazza A, Campese VM. A Controlled, Prospective Study of the Effects of Atorvastatin on Proteinuria and Progression of Kidney Disease. Am J Kidney Dis. 2003 Mar;41(3):565-70.

Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Terry M. Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A Model to Predict Survival in Patients With End-Stage Liver Disease. Hepatology. 2001 Feb;33(2):464-70.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study
Group. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Ann Intern Med. 1999 Mar 16;130(6):461-70.

Wolfson M, Piraino B, Hamburger RJ, Morton AR for the Icodextrin Study Group. A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Icodextrin in Peritoneal Dialysis. Am J Kidney Dis. 2002 Nov;1055-1065.

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JWC, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de
Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson P, Siegert S, Sinico A, Tesar V, Westman K, Pusey C. A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies. N Engl J Med. 2003 Jul 3;349(1):36-44.

Cohn JN, Tognoni G, for the Valsartan Heart Failure Trial Investigators. A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure. N Engl J Med. 2001 Dec 6;345(23):1667-75.

Eagle KA, Chair. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery-Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002 Feb 6;39(3):542-53.

Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore L, Librera M, Villari B, Colombo A, Ricciardelli B. Acetylcysteine and Contrast Agent-Associated Nephrotoxicity. J Am Coll Cardiol. 2002 Jul 17;40(2):298-303.

Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF. Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention: A Randomized Controlled Trial. JAMA. 2003 Feb 5;289(5):553-8.

Shyu KG, Cheng JJ, Kuan P. Acetylcysteine Prevents against Acute Renal Damage in Patients with Abnormal Renal Function Undergoing a Coronary Procedure. J Am Coll Cardiol. 2002 Oct 16;40(8):1383-8.

Diaz-Sandoval LJ, Kosowsky D, Losordo DW. Acetylcysteine to Prevent Angiography-Related Renal Tissue Injury (The APART Trial). Am J Cardiol. 2002 Feb 1;89(3):356-8.

Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB. Acute Humoral Rejection in Kidney Transplantation: II. Morphology, Immunopathology, and Pathologic Classification. J Am Soc Nephrol. 2002 Mar;13(3):779-87.

Drakeley AJ, Le Roux PA, Anthony J, Penny J. Acute Renal Failure Complicating Severe Preeclampsia Requiring Admission to an Obstetric Intensive Care Unit. Am J Obstet Gynecol. 2002 Feb;186(2):253-6.

Tsai HM. Advances in the Pathogenesis, Diagnosis, and Treatment of Thrombotic Thrombocytopenic Purpura. J Am Soc Nephrol. 2003 Apr;14(4):1072-81.

Weber KT. Aldosterone in Congestive Heart Failure. N Engl J Med. 2001 Dec 6;345(23):1689-97.

Ingelfinger JR. Ambulatory Blood-Pressure Monitoring as a Predictive Tool. N Engl J Med. 2002 Sep 12;347(11):778-9.

Baker EH, Duggal A, Dong Y, Ireson NJ, Wood M, Markandu ND, MacGregor, GA. Amiloride, a Specific Drug for Hypertension in Black People With T594M Variant? Hypertension. 2002 Jul;40(1):13-7.

Lorenz M, Kletzmayr J, Perschl A, Furrer A, Hörl WH, Sunder-Plassmann G. Anemia and Iron Deficiencies among Long-Term Renal Transplant Recipients. J Am Soc Nephrol. 2002 Mar;13(3):794-7.

Fogo AB. Approach to Renal Biopsy. Am J Kidney Dis. 2003 Oct;42(4):826-36.

Thakar CV, Liangos O, Yared JP, Nelson D, Piedmonte MR, Hariachar S, Paganini EP. ARF After Open-Heart Surgery: Influence of Gender and Race. Am J Kidney Dis. 2003 Apr;41(4):742-51.

Klassen PS, Lowrie EG, Beddan DN, Deong ER, Colasonato JA, Szczech LA, Lazarus JM, Owen WF. Association between Pulse Pressure and Mortality in Patients Undergoing Maintenance Hemodialysis. JAMA. 2002 Mar 27;287(12):1548-55.

Marwah DS, Korbet SM.Timing of complications in percutaneous renal biopsy: what is the optimal period of observation? Am J Kidney Dis. 1996 Jul;28(1):47-52.

Nass K, O'Neill WC. Bedside Renal Biopsy: Ultrasound Guidance by the Nephrologist. Am J Kidney Dis. 1999 Nov;34(5):955-9.

Ogata H, Ritz E, Odoni G, Amann K, Orth SR. Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors. J Am Soc Nephrol. 2003 Apr;14(4):959-67.

Fishman JA. BK Virus Nephropathy-Polyomavirus Adding Insult to Injury. N Engl J Med. 2002 Aug 15;347(7):527-30.

Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone Marrow Stem Cells Contribute to Repair of the Ischemically Injured Renal Tubule. J Clin Invest. 2003 Jul;112(1):42-9. Epub 2003 Jun 16.

Stewart JH, Buccianti G, Agodoa L, Disney, Wolfe RA, Boyle P, Maisonneuve P. Cancers of the Kidney and Urinary Tract in Patients on Dialysis for End-Stage Renal Disease: Analysis of Data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003 Jan;14(1):197-207.

Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison L. Cardiac and Renal Effects of Standard Versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycystic Kidney Disease: Results of a Seven-Year Prospective Randomized Study. J Am Soc Nephrol. 2002 Jul;13(7):1733-9.

Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM. Cardiac Calcification in Adult Hemodialysis Patients: A Link Between End-Stage Renal Disease and Cardiovascular Disease? J Am Coll Cardiol. 2002 Feb 20;39(4):695-701.

London GM. Cardiovascular Disease in Chronic Renal Failure: Pathophysiologic Aspects. Semin Dial. 2003 Mar-Apr;16(2):85-94.

Ifudu O. Care of Patients Undergoing Hemodialysis. N Engl J Med. 1998 Oct 8;339(15):1054-62.

Coblyn JS, McClusky RT. Case 3-2003: A 36-Year-Old Man with Renal Failure, Hypertension, and Neurologic Abnormalities. N Engl J Med. 2003 Jan 23;348(4):333-42.

Case 30-1995: A 69-year-old woman with lupus erythematosus and painful skin lesions of the feet. N Engl J Med. 1995 Sep 28;333(13):862-8.

St Peter WL, Schoolwerth AC, McGowan T, McClellan WM. Chronic Kidney Disease: Issues and Establishing Programs and Clinics for Improved Patient Outcomes. Am J Kidney Dis. 2003 May;41(5):903-24.

Rahman M, Smith MC. Chronic Renal Insufficiency: A Diagnostic and Therapeutic Approach. Arch Intern Med. 1998 Sep 14;158(16):1743-52.

Batlle D. Clinical and Cellular Markers of Diabetic Nephropathy. Kidney Int. 2003 Jun;63(6):2319-30.

Parmar MS. Clinical Review: Chronic Renal Disease. BMJ. 2002 Jul 13;325(7355):85-90.

Russo D, Minutolo R, Pisani A, Esposits R, Signorelli G Andreucci M, and Balletta MM. Coadministration of Losartan and Enalapril Exerts Additive Antiproteinuric Effect in IgA Nephropathy. Am J Kidney Dis. 2001 Jul;38(1):18-25.

Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination Treatment of Angiotensin-II Receptor Blocker and Angiotensin-Converting-Enzyme Inhibitor in Non-Diabetic Renal Disease (COOPERATE): A Randomised Controlled Trial. Lancet. 2003 Jan 11;361(9352):117-24.

Lorgh Lm Schiachi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarine A. Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic
Hypercaliuria. N Engl J Med. 2002 Jan 10;346(2):77-84.

Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of Interest in the Debate over Calcium-Channel Antagonists. N Engl J Med. 1998 Jan 8;338(2):101-6.

Zarrinkalam KH, Stanley JM, Gray J, Oliver N, Faull RJ. Connective Tissue Growth Factor and Its Regulation in the Peritoneal Cavity of Peritoneal Dialysis Patients. Kidney Int. 2003 Jul;64(1):331-8.

Jassal SV, Lok CE, Walele A, Bargman JM. Continued Transplant Immunosuppression May Prolong Survival after Return to Peritoneal Dialysis: Results of a Decision Analysis. Am J Kidney Dis. 2002 Jul;40(1):178-83.

Sandler CM. Contrast-Agent-Induced Acute Renal Dysfunction-Is Iodixanol the Answer? N Engl J Med. 2003 Feb 6;348(6):551-3.

Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002 Dec 18;288(23):2998-3007.

Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM. C-Reactive Protein and Cardiovascular Disease in Peritoneal Dialysis Patients.
Kidney Int. 2002 Oct;62(4):1417-22.

Back MR, Bandyk DF. Current Status of Surveillance of Hemodialysis Access Grafts. Ann Vasc Surg. 2001 Jul;15(4):491-502.

Haubitz M, Bohnenstengel F, Brunkhorst R, Schwab M, Hofmann U, Busse D. Cyclophosphamide Pharmacokinetics and Dose Requirements in Patients with Renal Insufficiency. Kidney Int. 2002 Apr;61(4):1495-501.

Klein M, Radhakrishnan J, MD, Appel G. Cyclosporine Treatment of Glomerular Diseases. Annu Rev Med. 1999;50:1-15.

Pirson Y, Cahuvreau D. Cystic Diseases of the Kidney. Chapter 9 of ???

Schiffl H, Lang SM, Fischer R. Daily Hemodialysis and the Outcome of Acute Renal Failure. N Engl J Med. 2002 Jan 31;346(5):305-10.

Bonventre JV. Daily Hemodialysis-Will Treatment Each Day Improve the Outcome in Patients with Acute Renal Failure? N Engl J Med. 2002 Jan 31;346(5):362-4.

Ingelfinger JR. Diet and Kidney Stones. N Engl J Med. 2002 Jan 10;346(2):74-6.

Coyne DW, Grieff M, Ahya SN, Giles K, Norwook d, Slatopolsky E. Differential Effects of Acute Administration of 19-Nor-1,25-Dihydroxy-Vitamin D2 and 1,25-Dihydroxy-Vitamin D3 on Serum Calcium and Phosphorus in Hemodialysis Patients. Am J Kidney Dis. 2002 Dec;40(6):1283-8.

Mehta RL, Pascual MT, Soroko S, Chertow GM, for the PICARD Study Group. Diuretics, Mortality, and Nonrecovery of Renal Function in Acute Renal Failure. JAMA. 2002 Nov 27;288(20):2547-53.

Campbell R, Sangalli F, Perticucci P, Aros C, Viscarra C, Perna A, Remuzzi R, Bertocchi F, Fagiani L, Remuzzi G, Ruggenenti P. Effect of Pravastatin on Proteinuria in Patients With Well-Controlled Hypertension, Effects of Combined ACE Inhibitor and Angiotensin II Antagonist Treatment in Human Chronic Nephropathies. Kidney Int. 2003 Mar;63(3):1094-103.

Writing Group of the PREMIER Collaborative Research Group. Effects of Comprehensive Lifestyle Modification on Blood Pressure Control: Main Results of the PREMIER Clinical Trial. JAMA. 2003 Apr 23-30;289(16):2083-93.

Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E,
Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R for the HEMO Study Group. Effects of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis. N Engl J Med. 2002 Dec 19;347(25):2010-9.

Brenner BM, Cooper ME, deZeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S for the RENAAL Study Investigators. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med. 2001 Sep 20;345(12):861-9.

Isenberg DA, Karassa FB. Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis. N Engl J Med. 2001 Feb 1;344(5):382-3.

Chan TM, Li FK, Tang CSO, Wong RWS, Fang GX, Ji YL, Lau CS, Wong AKM, Tong MKL, Chan EW, Lai KN for the Hong Kong-Guangzhou Nephrology Study Group. Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis. N Engl J Med. 2000 Oct 19;343(16):1156-62.

Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial Function and Oxidative Stress in Renovascular Hypertension. N Engl J Med. 2002 Jun 20;346(25):1954-62.

Lin JL, Lin-Tan DT, Hsu KH, Yu CC. Environmental Lead Exposure and Progression of Chronic Renal Diseases in Patients without Diabetes. N Engl J Med. 2003 Jan 23;348(4):277-86.

Schiffmann R, Kopp JH, Austin HA, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO. Enzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial. JAMA. 2001 Jun 6;285(21):2743-9.

Hsu CH, McCulloch CE, Curhan GC. Epidemiology of Anemia Associated with Chronic Renal Insufficiency among Adults in the United States: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2002 Feb;13(2):504-10.

Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, Narasimhan N, Wagnild, JP. Epidemiology of Hemodialysis Vascular Access Infections from Longitudinal Infection Surveillance Data: Predicting the Impact of NKF-DOQ1 Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis. 2002 Mar;39(3):549-55.

Floege J. Evidence-Based Recommendations for Immunosuppression in IgA Nephropathy: Handle with Caution. Nephrol Dial Transplant. 2003 Feb;18(2):241-5.

Bhatia S, Silverberg NB, Don PC, Weinberg JM. Extensive Calcinosis Cutis in Association with Systemic Lupus Erythematosus. Acta Derm Venereol. 2001 Nov-Dec;81(6):446-7.

Korbet SM, Lewis EJ. Schwartz MM, Reichlin M, Evans J, Rohde RD for the Lupus Nephritis Collaborative Study Group. Factors Predictive of Outcome in Severe Lupus Nephritis. Am J Kidney Dis. 2000 May;35(5):904-14.

Rivas P, Polo J, de Górgolas M, Fernández-Guerrero M. Fatal Lactic Acidosis Associated with Tenofovir. BMJ. 2003 Sep 27;327(7417):711.

Walter RB, Joerger M, Pestalozzi BC. Gemcitabine-Associated Hemolytic-Uremic Syndrome. Am J Kidney Dis. 2002 Oct;40(4):E16.

Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, Lee R, Mekala A, Sung J, Komaroff AL, Bates DW. Guided Medication Dosing for Inpatients with Renal Insufficiency. JAMA. 2001 Dec 12;286(22):2839-44.

Imai H, Oyama Y, Miura AB, Endoh M, Sakai H. Hematopoietic Cell Transplantation-Related Nephropathy in Japan. Am J Kidney Dis. 2000 Sep;36(3):474-80.

Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis Vascular Access Preferences and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2002 Jun;61(6):2266-71.

Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins F, Brown J, Drayson MT, Selby PJ for the Medical Research Council Adult Leukemia Working Party. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma. N Engl J Med. 2003 May 8;348(19):1875-83.

Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003 Jun 12;348(24):2407-15.

Donadio JV, Grande JP. IgA Nephropathy. N Engl J Med. 2002 Sep 5;347(10):738-48.

Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of Dialysis Modality on Survival of New ESRD Patients with Congestive Heart Failure in the United States. Kidney Int. 2003 Sep;64(3):1071-9.

Karsou SA, Jaber BL, Pereira BJG. Impact of Intermittent Hemodialysis Variables on Clinical Outcomes in Acute Renal Failure. Am J Kidney Dis. 2000 May;35(5):980-91.

Holt S, Goodier D, Marley R, Patch P, Burroughs A, Fernando B, Harry D, Moore K. Improvement in Renal Function in Hepatorenal Syndrome with N-acetylcysteine. Lancet. 1999 Jan 23;353(9149):294-5.

Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes. N Engl J Med. 2002 Sep 12;347(11):797-805.

Marsden PA. Increased Body Lead Burden-Cause or Consequence of Chronic Renal Insufficiency? N Engl J Med. 2003 Jan 23;348(4):345-7.

Fung F, Sherrard DJ, Gillen DL, Wong C, Kestenbaum B, Seliger S, Ball A, Stehman-Breen, C. Increased Risk for Cardiovascular Mortality among Malnourished End-Stage Renal Disease Patients. Am J Kidney Dis. 2002 Aug;40(2):307-14.

Noel C, Hazzan M, Boukelmoune M, Jaillard S, Dufossé F, Codaccioni MX, Pruvot FR, Leliève G. Indication for Allograft Nephrectomy after Irreversible Rejection: Is There an Ideal Delay? Transplant Proc. 1997 Feb-Mar;29(1-2):145-6.

DeVriese AS, Verbeke F, Schrijvers BF, Lameire NH. Is Folate a Promising Agent in the Prevention and Treatment of Cardiovascular Disease in Patients with Renal Failure? Kidney Int. 2002 Apr;61(4):1199-209.

Bunnapradist S, Cho YW, Cecka JM, Wilkinson A, Danovitch GM. Kidney Allograft and Patient Survival in Type I Diabetic Recipients of Cadaveric Kidney Alone Versus Simultaneous Pancreas/Kidney Transplants: A Multivariate Analysis of the UNOS Database. J Am Soc Nephrol. 2003 Jan;14(1):208-13.

Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): A Novel Biomarker for Human Renal Proximal Tubule Injury. Kidney Int. 2002 Jul;62(1):237-44.

Lee TM, Su SF, Tsai CH. Effect of pravastatin on proteinuria in patients with well-controlled hypertension. Hypertension. 2002 Jul;40(1):67-73.

Alarcón-Segovia D, Tumlin JA, Furie RA, McKay JD, Cardiel MH, Strand V, Bagin RG, Linnik MD, Hepburn B, and the LJP 394 Investigator Consortium. LJP 394 for the Prevention of Renal Flare in Patients With Systemic Lupus Erythematosus: Results From a Randomized, Double-Blind, Placebo-Controlled Study. Arthritis Rheum. 2003 Feb;48(2):442-54.

Lameire N, Vanholder R, Van Biesen W. Loop Diuretics for Patients with Acute Renal Failure: Helpful or Harmful? JAMA. 2002 Nov 27;288(20):2599-601.

Fleisher LA, Eagle KA. Lowering Cardiac Risk in Noncardiac Surgery. N Engl J Med. 2001 Dec 6;345(23):1677-82.

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Cannel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002 Dec 18;288(23):2981-97.

The ALLHAT Officers. Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002 Dec 18;288(23):2998-3007.

Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K. Medial Artery Calcification in ESRD Patients Is Associated with Deposition of Bone Matrix Proteins. Kidney Int. 2002 Feb;61(2):638-47.

Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH. Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells. J Am Soc Nephrol. 2003 Jan;14(1):1-10.

Henry RMA, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA. Mild Renal Insufficiency Is Associated with Increased Cardiovascular Mortality: The Hoorn Study. Kidney Int. 2002 Oct;62(4):1402-7.

Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of Hereditary Amyloidosis As AL (Primary) Amyloidosis. N Engl J Med. 2002 Jun 6;346(23):1786-91.

Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB. Monoclonal Gammopathy: Significance and Possible Causality in Renal Disease. Am J Kidney Dis. 2003 Jul;42(1):87-95.

Yasuda M, Akiba T, Nihei H. Multicenter Clinical Trial of 22-oxa-1,25-dihydroxyvitamin D3 for Chronic Dialysis Patients. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S108-11.

Hyman MH, Whittemore VH. National Institutes of Health Consensus Conference: Tuberous Sclerosis Complex. Arch Neurol. 2000 May;57(5):662-5.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Ann Intern Med. 2003 Jul 15;139(2):137-47.

Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JR, Munshi N, Crawford ED. Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer. N Engl J Med. 2001 Dec 6;345(23):1655-9.

Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron Number in Patients with Primary Hypertension. N Engl J Med. 2003 Jan 9;348(2):101-8.

Remuzzi G, Schieppati A, Ruggenenti P. Nephropathy in Patients with Type 2 Diabetes. N Engl J Med. 2002 Apr 11;346(15):1145-51.

Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. N Engl J Med. 2003 Feb 6;348(6):491-9.

Akizawa T, Shiizaki K, Hatamura I, Kamimura M, Mizobuchi M, Narukawa N, Sumikado S, Sakaguchi T, Negi S, Ogata H, Kinugasa E. New Strategies for the Treatment of Secondary Hyperparathyroidism. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S100-3.

Irish WD, McCollum DA, Tesi RJ, Owen AB, Brennan DC, Jane E. Bailly JE, Schnitzler MA. Nomogram for Predicting the Likelihood of Delayed Graft Function in Adult Cadaveric Renal Transplant Recipients. J Am Soc Nephrol. 2003 Nov;14(11):2967-74.

Levey AS. Nondiabetic Kidney Disease. N Engl J Med. 2002 Nov 7;347(19):1505-11.

Schnuelle P, Van Der Heide JH, Tegzess A, Verburgh CA, Paul LC, Van Der Woude FJ, De Fijter JW. Open Randomized Trial Comparing Early Withdrawal of either Cyclosporine or Mycophenolate Mofetil in Stable Renal Transplant Recipients Initially Treated with a Triple Drug Regimen. J Am Soc Nephrol. 2002 Feb;13(2):536-43.

Oliveira GHM, Schirger A. Page Kidney. N Engl J Med. 2003 Jan 9;348(2):129

Drüeke TB, McCarron DA. Paracalcitol as Compared with Calcitriol in Patients Undergoing Hemodialysis. N Engl J Med. 2003 Jul 31;349(5):496-9.

Lameire N, Vanholder R. Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism, Pathophysiologic Features and Prevention of Human and Experimental Acute Tubular Necrosis. J Am Soc Nephrol. 2001 Feb;12 Suppl 17:S20-32.

Palmer LP, Silverman ES, Weiss ST, Drazen JM. Pharmacogenetics of Asthma. Am J Respir Crit Care Med. 2002 Apr 1;165(7):861-6.

Snoeck R, Bossens M, Parent D, Delaere B, Degreef H, Van Ranst M, Noël JC, Wulfsohn MS, Rooney JF, Jaffe HS, De Clercq E. Phase II Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Cidofovir Topical Gel for the Treatment of Patients with Human Papillomavirus Infection. Clin Infect Dis. 2001 Sep 1;33(5):597-602. Epub 2001 Jul 26

Forman LM, Lucey MR. Predicting the Prognosis of Chronic Liver Disease: An Evolution from Child to MELD. Hepatology. 2001 Feb;33(2):473-5.

Bagon JA, Vernaeve H, De Muylder X, Lafontaine JJ, Martens J, Van Roost G. Pregnancy and Dialysis. Am J Kidney Dis. 1998 May;31(5):756-65.

Hou S. Pregnancy in Chronic Renal Insufficiency and End-StageRenal Disease, Am J Kidney Dis. 1999 Feb;33(2):235-52.

Moroni G, Quaglini S, Banfi G, Caloni M, Finazzi S, Ambroso G, Corno G, Ponticelli C. Pregnancy in Lupus Nephritis. Am J Kidney Dis. 2002 Oct;40(4):713-20.

Mok CC, Wong RWS. Pregnancy in Systemic Lupus Erythematosus. Postgrad Med J. 2001 Mar;77(905):157-65.

Chao AS, Huang JY, Lien R, Kung FT, Chen PJ, Hsieh PCC. Pregnancy in Women Who Undergo Long-Term Hemodialysis. Am J Obstet Gynecol. 2002 Jul;187(1):152-6.

De Vriese A. Prevention and Treatment of Acute Renal Failure in Sepsis. J Am Soc Nephrol. 2003 Mar;14(3):792-805.

Hostetter TH. Prevention of End-Stage Renal Disease Due to Type 2 Diabetes. N Engl J Med. 2001 Sep 20;345(12):910-2.

Tepel M, van der Giet M, Schwarzfeld C, Laufer
U, Liermann D, Zidek W. Prevention of Radiographic-Contrast-Agent-Induced Reductions in Renal
Function by Acetylcysteine. N Engl J Med. 2000 Jul 20;343(3):180-4.

Cohen EP. Radiation Nephropathy after Bone Marrow Transplantation. Kidney Int. 2000 Aug;58(2):903-18.

Wheeler DS. Radiological Case of the Month: Transient Acute Renal Failure of the Newborn. Arch Pediatr Adolesc Med. 1999 Apr;153(4):423-4.

Muray S, Martin S, Amoedo ML, Carcia C, Jornet AR, Vera M, Oliveras A, Gomez X, Craver L, Real MI, Garcia L, Botey A, Montanyá X, Fernández E. Rapid Decline in Renal Function Reflects Reversibility and Predicts the Outcome after Angioplasty in Renal Artery Stenosis. Am J Kidney Dis. 2002 Jan;39(1):60-6.

Jennette JC. Rapidly Progressive Crescentic Glomerulonephritis. Kidney Int. 2003 Mar;63(3):1164-77.

Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS. Recommendations for the Outpatient Surveillance of Renal Transplant
Recipients. J Am Soc Nephrol. 2000 Oct;11 Suppl 15:S1-86.

Komatsuda A, Morita K, Ohanti H, Yamaguchi A, Miura AB. Remission of the Nephrotic Syndrome in a Patient with Renal Amyloidosis Due to Rheumatoid Arthritis Treated with Prednisone and Methotrexate. Am J Kidney Dis. 1998 Nov;32(5):E7.

Palmer BF. Renal Dysfunction Complicating the Treatment of Hypertension. N Engl J Med. 2002 Oct 17;347(16):1256-61.

Ramos F, Kotliar C, Alvarez D, Baglivo H, Rafaelle P,
Londero H, Sánchez R, Wilcox CS. Renal Function and Outcome of PTRA and Stenting for Atherosclerotic Renal Artery Stenosis. Kidney Int. 2003 Jan;63(1):276-82.

Hörl WH. Renal Osteodystrophy: Role of Calcimimetics. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S104-7.

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins R, Rohde R, Raz I for the Collaborative Study Group. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes. N Engl J Med. 2001 Sep 20;345(12):851-60.

Kim SJ, Goldstein M, Szabo T, Pierratos A. Resolution of Massive Uremic Tumoral Calcinosis with Daily Nocturnal Home Hemodialysis. Am J Kidney Dis. 2003 Mar;41(3):E12.

Sam AD, Morasch MD, Jeremy Collins J, Song G, Chen R, Pereles FS. Safety of Gadolinium Contrast Angiography in Patients with Chronic Renal Insufficiency. J Vasc Surg. 2003 Aug;38(2):313-8.

Euvrard S, Kanitakis J, Claudy A. Skin Cancers after Organ Transplantation. N Engl J Med. 2003 Apr 24;348(17):1681-91.

Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR, Agarwal R, Eschbach JW, Fadem SZ, Trout JR, Strobos J, Warmock DG for the Ferrlecit Publication Committee. Sodium Ferric Gluconate Complex in Hemodialysis Patients: Adverse Reactions Compared to Placebo and Iron Dextran. Kidney Int. 2002 May;61(5):1830-9.

Saraiva MJM. Sporadic Cases of Hereditary Systemic Amyloidosis. N Engl J Med. 2002 Jun 6;346(23):1818-9.

Thompson B, Burns A. Subarachnoid Hemorrhages in Vasculitis. Am J Kidney Dis. 2003 Sep;42(3):582-5.

Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy. N Engl J Med. 2003 Jul 31;349(5):446-56.

Pasternak RC. The ALLHAT Lipid Lowering Trial-Less is Less. JAMA. 2002 Dec 18;288(23):3042-4.

Bach JF. The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases. N Engl J Med. 2002 Sep 19;347(12):911-20.

Parving HH, Lehnert H, Bröchner-Mortenses J, Gomis R, Andersen S, Arner P for the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes. N Engl J Med. 2001 Sep 20;345(12):870-8.

Rademacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberger U, Burg M, Luft FC, Gwinner W, Haller H. The Renal Arterial Resistance Index and Renal Allograft Survival. N Engl J Med. 2003 Jul 10;349(2):115-24.

Appel LJ. The Verdict from ALLHAT-Thiazide Diuretics Are the Preferred Initial Therapy for Hypertension. JAMA. 2002 Dec 18;288(23):3039-42.

Bühler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N,. Saidman SL, Sackstein R, McAfee S, Dey B, Colby C, Cosimi A. Induction of kidney allograft tolerance after transient Lymphohematopoietic Chimerism in Patients with Multiple Myeloma
and End-Stage Renal Disease. Transplantation. 2002 Nov 27;74(10):1405-9.

González EA, Lund RJ, Martin KJ, McCartney JE, Tondravi MM, Sampath TK, Hruska KA. Treatment of a Murine Model of High-Turnover Renal Osteodystrophy by Exogenous BMP-7. Kidney Int. 2002 Apr;61(4):1322-31.

Langford CA. Treatment of ANCA-Associated Vasculitis. N Engl J Med. 2003 Jul 3;349(1):3-4.

Sibai BM. Treatment of Hypertension in Pregnant Women. N Engl J Med. 1996 Jul 25;335(4):257-65.

Besarab A.Vascular Access Surveillance: Using Pressures and Flows, Part Two of Two. American Society of Nephrology Annual Scientific Meeting, October, 2000. Online slide/audio presentation.

Vitamin D: Mechanism, Function and New Analogs, DeLuca HF. MPBC/Bone & Osteoporosis Program, A Joint Seminar, Northwestern University, October 21, 2003.

Vanholder R, Van Biesen W, Lameire N. What Is the Renal Replacement Method of First Choice for Intensive Care Patients? J Am Soc Nephrol. 2001 Feb;12 Suppl 17:S40-3.

Smak Gregoor PJHS, De SéVaux RGL, Ligtenberg G, Hoitsma AJ, Hené RJ, Weimar W. Withdrawal of Cyclosporine or Prednisone Six Months after Kidney Transplantation in Patients on Triple Drug Therapy: A Randomized, Prospective, Multicenter Study. J Am Soc Nephrol. 2002 May;13(5):1365-73.

Ohashi N, Yonemura K, Sugiura T, Isozaki T, Togawa A, Fujigaki Y, Yamamoto T, Hishida A. Withdrawal of Interferon-alpha Results in Prompt Resolution of Thrombocytopenia and Hemolysis but Not Renal Failure in Hemolytic Uremic Syndrome Cause by Interferon-alpha. Am J Kidney Dis. 2003 Mar;41(3):E10.